当前位置:首页 - 行情中心 - 诚意药业(603811) - 财务分析 - 现金流量表

诚意药业

(603811)

  

流通市值:45.92亿  总市值:45.92亿
流通股本:3.27亿   总股本:3.27亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金399,201,477.13180,167,320.67730,850,380.46501,135,264.84
  收到的税费返还339,886.57-8,850.131,874,312.28
  收到其他与经营活动有关的现金10,354,311.072,403,563.1428,854,732.4719,647,440.35
  经营活动现金流入小计409,895,674.77182,570,883.81759,713,963.06522,657,017.47
  购买商品、接受劳务支付的现金62,492,624.5628,150,473.54129,039,561.83103,346,584.07
  支付给职工以及为职工支付的现金64,208,557.4431,823,323.47123,019,470.5897,250,131.31
  支付的各项税费53,112,537.4727,048,397.5284,620,468.7763,772,880.3
  支付其他与经营活动有关的现金88,817,476.7640,041,571.95217,318,612.84153,303,154.45
  经营活动现金流出小计268,631,196.23127,063,766.48553,998,114.02417,672,750.13
  经营活动产生的现金流量净额141,264,478.5455,507,117.33205,715,849.04104,984,267.34
二、投资活动产生的现金流量:
  取得投资收益收到的现金11,250,500-9,000,4009,000,400
  处置固定资产、无形资产和其他长期资产收回的现金净额216,372.560,00077,096,282.8363,346,666.67
  投资活动现金流入小计11,466,872.560,00086,096,682.8372,347,066.67
  购建固定资产、无形资产和其他长期资产支付的现金12,935,360.969,747,122.4759,887,825.9156,346,116.06
  支付其他与投资活动有关的现金--27,134.81-
  投资活动现金流出小计12,935,360.969,747,122.4759,914,960.7256,346,116.06
  投资活动产生的现金流量净额-1,468,488.46-9,687,122.4726,181,722.1116,000,950.61
三、筹资活动产生的现金流量:
  取得借款收到的现金30,000,0001,000,000177,803,912.59117,800,000
  收到其他与筹资活动有关的现金---49,316.16
  筹资活动现金流入小计30,000,0001,000,000177,803,912.59117,849,316.16
  偿还债务支付的现金53,000,00038,000,000389,265,886.58249,410,867.22
  分配股利、利润或偿付利息支付的现金81,973,738.361,351,975.576,695,496.6874,575,337.16
  支付其他与筹资活动有关的现金9,154,208.847,875,647.7267,825,880.12350,775.57
  筹资活动现金流出小计144,127,947.247,227,623.22533,787,263.38324,336,979.95
  筹资活动产生的现金流量净额-114,127,947.2-46,227,623.22-355,983,350.79-206,487,663.79
四、汇率变动对现金及现金等价物的影响-238,901.62-150,712.63288,581.42162,686.43
五、现金及现金等价物净增加额25,429,141.26-558,340.99-123,797,198.22-85,339,759.41
  加:期初现金及现金等价物余额169,447,913.66169,447,913.66293,245,111.88293,245,111.88
  期末现金及现金等价物余额194,877,054.92168,889,572.67169,447,913.66207,905,352.47
补充资料:
  净利润113,936,959.74-200,786,260.18-
  资产减值准备6,910,539.37-26,596,192.71-
  固定资产和投资性房地产折旧46,251,235.89-90,619,884.71-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧46,251,235.89-90,619,884.71-
  无形资产摊销1,218,874.68-4,507,271.52-
  长期待摊费用摊销106,738.08-1,019,034.05-
  处置固定资产、无形资产和其他长期资产的损失-111,916.62--289,868.88-
  固定资产报废损失251,882.51-3,174,063.83-
  财务费用2,868,698.65-10,855,888.83-
  投资损失-20,035,272.46--43,393,492.07-
  递延所得税216,584.04--1,988,633.05-
  其中:递延所得税资产减少1,033,493.59--354,813.98-
    递延所得税负债增加-816,909.55--1,633,819.07-
  存货的减少20,186,527.22--20,829,327.09-
  经营性应收项目的减少-25,606,795.66--19,242,435.62-
  经营性应付项目的增加-5,311,082.34-24,388,187.11-
  不涉及现金收支的投资和筹资活动金额其他项目--476,429.42-
  现金的期末余额194,877,054.92-169,447,913.66-
  减:现金的期初余额169,447,913.66-293,245,111.88-
  现金及现金等价物的净增加额25,429,141.26--123,797,198.22-
公告日期2025-08-272025-04-302025-04-302024-10-29
审计意见(境内)标准无保留意见
TOP↑